Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Peritoneal Neoplasms 2Mesothelioma, Malignant 2Adrenocortical Carcinoma 2Thrombocytopenia 1Stomach Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoma 1Laryngeal Neoplasms 1Intraocular Lymphoma 1Hypopharyngeal Neoplasms 1Hyperthermia 1Glioma 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

Temozolomide 69Bevacizumab 40Radiotherapy 22Magnetic Resonance Spectroscopy 20Irinotecan 17Specimen Handling 10Carboplatin 10Carmustine 9X-Rays 7Radiation 7olaparib 6Surgical Procedures, Operative 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Nivolumab 6Everolimus 6Cyclophosphamide 6Biopsy 6trametinib 5Thalidomide 5Cisplatin 5pembrolizumab 4palbociclib 4fluorodopa F 18 4erdafitinib 4dabrafenib 4Lomustine 4Etoposide 4Drug Therapy 4Doxorubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Glioma × sodium thiosulfate × Clear all
NCT00075387 2022-05-03

Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

OHSU Knight Cancer Institute

Phase 2 Unknown
48 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡